Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Interest Expenses (2017 - 2025)

Historic Interest Expenses for Ekso Bionics Holdings (EKSO) over the last 11 years, with Q3 2025 value amounting to $18000.0.

  • Ekso Bionics Holdings' Interest Expenses fell 7721.52% to $18000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $214000.0, marking a year-over-year decrease of 2246.38%. This contributed to the annual value of $269000.0 for FY2024, which is 1092.72% down from last year.
  • Ekso Bionics Holdings' Interest Expenses amounted to $18000.0 in Q3 2025, which was down 7721.52% from $65000.0 recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' Interest Expenses registered a high of $112000.0 during Q1 2023, and its lowest value of $18000.0 during Q3 2025.
  • For the 5-year period, Ekso Bionics Holdings' Interest Expenses averaged around $52421.1, with its median value being $59000.0 (2024).
  • Its Interest Expenses has fluctuated over the past 5 years, first surged by 31481.48% in 2023, then tumbled by 7721.52% in 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Interest Expenses (Quarter) stood at $36000.0 in 2021, then skyrocketed by 83.33% to $66000.0 in 2022, then changed by 0.0% to $66000.0 in 2023, then decreased by 10.61% to $59000.0 in 2024, then plummeted by 69.49% to $18000.0 in 2025.
  • Its last three reported values are $18000.0 in Q3 2025, $65000.0 for Q2 2025, and $72000.0 during Q1 2025.